The European Union’s health regulator on Friday raised concerns over the decreasing effectiveness of Covid-19 antibody therapies to treat patients as emerging virus variants are challenging treatment approaches.
The European Union’s health regulator on Friday raised concerns over the decreasing effectiveness of Covid-19 antibody therapies to treat patients as emerging virus variants are challenging treatment approaches.